BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 7736909)

  • 1. Metabolism of L-689,502 by rat liver slices to potent HIV-1 protease inhibitors.
    Balani SK; Pitzenberger SM; Schwartz MS; Ramjit HG; Thompson WJ
    Drug Metab Dispos; 1995 Feb; 23(2):185-9. PubMed ID: 7736909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolites of L-735,524, a potent HIV-1 protease inhibitor, in human urine.
    Balani SK; Arison BH; Mathai L; Kauffman LR; Miller RR; Stearns RA; Chen IW; Lin JH
    Drug Metab Dispos; 1995 Feb; 23(2):266-70. PubMed ID: 7736923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose-dependent toxicokinetics of L-689,502, a potent human immunodeficiency virus protease inhibitor, in rats and dogs.
    Lin JH; Chen IW; King J
    J Pharmacol Exp Ther; 1992 Oct; 263(1):105-11. PubMed ID: 1403775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro metabolism of a potent HIV-protease inhibitor (141W94) using rat, monkey and human liver S9.
    Singh R; Chang SY; Taylor LC
    Rapid Commun Mass Spectrom; 1996; 10(9):1019-26. PubMed ID: 8755234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism of 3-[2-(benzoxazol-2-yl)ethyl]-5-ethyl-6-methylpyridin-2 (1H)-one (L-696,229), an HIV-1 reverse transcriptase inhibitor, by rat liver slices and in humans.
    Balani SK; Kauffman LR; Arison BH; Olah TV; Goldman ME; Varga SL; O'Brien JA; Ramjit HG; Rooney CS; Hoffman JM
    Drug Metab Dispos; 1994; 22(2):200-5. PubMed ID: 7516852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biotransformation of 5-chloro-3-phenylthioindole-2-carboxamide (L-734,005) in rhesus monkeys and rat liver microsomes to a potent HIV-1 reverse transcriptase inhibitor.
    Balani SK; Goldman ME; Kauffman LR; Varga SL; O'Brien JA; Smith SJ; Olah TV; Ramjit HG; Schorn TW; Pitzenberger SM
    Drug Metab Dispos; 1993; 21(4):598-604. PubMed ID: 7690697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the metabolites of the peptidomimetic human immunodeficiency virus type 1 protease inhibitor SK&F 107461 in rats using liquid chromatography/mass spectrometry.
    Potts W; van Horn R; Anderson K; Blake T; Garver E; Joseph G; Dreyer G; Shu A; Heys R; Fong KL
    Drug Metab Dispos; 1995 Aug; 23(8):799-805. PubMed ID: 7493545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro metabolism of the HIV-1 protease inhibitor ABT-378: species comparison and metabolite identification.
    Kumar GN; Jayanti V; Lee RD; Whittern DN; Uchic J; Thomas S; Johnson P; Grabowski B; Sham H; Betebenner D; Kempf DJ; Denissen JF
    Drug Metab Dispos; 1999 Jan; 27(1):86-91. PubMed ID: 9884314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disposition of indinavir, a potent HIV-1 protease inhibitor, after an oral dose in humans.
    Balani SK; Woolf EJ; Hoagland VL; Sturgill MG; Deutsch PJ; Yeh KC; Lin JH
    Drug Metab Dispos; 1996 Dec; 24(12):1389-94. PubMed ID: 8971147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potent and selective inhibitors of human immunodeficiency virus protease structurally related to L-694,746.
    Franchetti P; Perlini P; Abu Sheikha G; Cappellacci L; Grifantini M; Loi AG; De Montis A; Pani A; Marongiu ME; La Colla P
    Antivir Chem Chemother; 1998 Jul; 9(4):303-9. PubMed ID: 9875409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liquid chromatography-mass spectrometry and liquid chromatography-NMR characterization of in vitro metabolites of a potent and irreversible peptidomimetic inhibitor of rhinovirus 3C protease.
    Zhang KE; Hee B; Lee CA; Liang B; Potts BC
    Drug Metab Dispos; 2001 May; 29(5):729-34. PubMed ID: 11302940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Orally active inhibitors of human leukocyte elastase. III. Identification and characterization of metabolites of L-694,458 by liquid chromatography-tandem mass spectrometry.
    Luffer-Atlas D; Vincent SH; Painter SK; Arison BH; Stearns RA; Chiu SH
    Drug Metab Dispos; 1997 Aug; 25(8):940-52. PubMed ID: 9280402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potent human immunodeficiency virus type 1 protease inhibitors that utilize noncoded D-amino acids as P2/P3 ligands.
    Jungheim LN; Shepherd TA; Baxter AJ; Burgess J; Hatch SD; Lubbehusen P; Wiskerchen M; Muesing MA
    J Med Chem; 1996 Jan; 39(1):96-108. PubMed ID: 8568831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potent and selective inactivation of human liver microsomal cytochrome P-450 isoforms by L-754,394, an investigational human immune deficiency virus protease inhibitor.
    Chiba M; Nishime JA; Lin JH
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1527-34. PubMed ID: 8531125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potent inhibition of the cytochrome P-450 3A-mediated human liver microsomal metabolism of a novel HIV protease inhibitor by ritonavir: A positive drug-drug interaction.
    Kumar GN; Dykstra J; Roberts EM; Jayanti VK; Hickman D; Uchic J; Yao Y; Surber B; Thomas S; Granneman GR
    Drug Metab Dispos; 1999 Aug; 27(8):902-8. PubMed ID: 10421617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo and in vitro metabolism studies on a class III antiarrhythmic agent.
    Vickers S; Duncan CA; Kari PH; Homnick CF; Elliott JM; Pitzenberger SM; Hichens M; Vyas KP
    Drug Metab Dispos; 1993; 21(3):467-73. PubMed ID: 8100503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolism of a new HIV-1 reverse transcriptase inhibitor, 3-[2-(benzoxazol-2-yl)ethyl]-5-ethyl-6-methylpyridin-2(1H)-one (L-696,229), in rat and liver slices.
    Balani SK; Pitzenberger SM; Kauffman LR; Arison BH; Ramjit HG; Goldman ME; O'Brien JA; King JD; Hoffman JM; Rooney CS
    Drug Metab Dispos; 1992; 20(6):869-76. PubMed ID: 1283569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of two phase I metabolites of bendamustine in human liver microsomes and in cancer patients treated with bendamustine hydrochloride.
    Teichert J; Baumann F; Chao Q; Franklin C; Bailey B; Hennig L; Caca K; Schoppmeyer K; Patzak U; Preiss R
    Cancer Chemother Pharmacol; 2007 May; 59(6):759-70. PubMed ID: 16957931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on the metabolism of the novel, selective cyclooxygenase-2 inhibitor indomethacin phenethylamide in rat, mouse, and human liver microsomes: identification of active metabolites.
    Remmel RP; Crews BC; Kozak KR; Kalgutkar AS; Marnett LJ
    Drug Metab Dispos; 2004 Jan; 32(1):113-22. PubMed ID: 14709628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Caffeine metabolism in liver slices during postnatal development in rats.
    Bienvenu T; Pons G; Rey E; Thiroux G; Olive G
    Drug Metab Dispos; 1993; 21(1):178-80. PubMed ID: 8095214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.